Shorter Combination treatment as effective as monotherapy for TB prevention in kids

To prevent tuberculosis (TB) in children with latent tuberculosis infection (which is not active but can become active), combination treatment with the medications rifapentine and isoniazid was as effective as longer treatment with only isoniazid, according to a study published online by JAMA Pediatrics.

Children account for a substantial portion of the global burden of active and . Treating latent tuberculosis infection (LTBI) in children is beneficial because it can prevent TB from developing and limits transmission of Mycobacterium tuberculosis, according to background information in the study.

M. Elsa Villarino, M.D., M.P.H., of the U.S. Centers for Disease Control and Prevention (CDC), Atlanta, and coauthors compared the safety and effectiveness of with rifapentine and isoniazid to treatment only with isoniazid. The compared 12, once-weekly doses of the combination drugs given with supervision by a healthcare professional with nine months of daily isoniazid treatment without supervision by a health care professional in children (ages 2 to 17 years) with latent tuberculosis infection from 29 study sites in the United States, Canada, Brazil, China and Spain. Of the 1,058 children enrolled, 905 were eligible for the evaluation of treatment effectiveness (471 in the combination-therapy group and 434 in the isoniazid-only group.

The cumulative proportion of children in whom TB was diagnosed was zero of 471 in the combination-therapy group vs. 3 of 434 in the isoniazid-only group, according to the study results. Neither group had any treatment-attributed hepatotoxicity (liver damage), serious adverse events or deaths.

"We found that combination therapy with rifapentine and isoniazid was well tolerated and safe in aged 2 to 17 years who were treated for LTBI," the study concludes.

Explore further

US urges shorter treatment for TB

More information: JAMA Pediatr. Published online January 12, 2015. DOI: 10.1001/jamapediatrics.2014.3158
Journal information: JAMA Pediatrics

Citation: Shorter Combination treatment as effective as monotherapy for TB prevention in kids (2015, January 12) retrieved 6 April 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments